Statistics
Publications
2
Citations
217
H-Index
2
Active since
2024
Affiliations
Robert Zorc is an author at Parker Institute for Cancer Immunotherapy specializing in jak inhibitors, immunotherapy, and oncology.
Publications per year
2024–2025
2
2
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
Divij Mathew, Melina E. Marmarelis, Caitlin Foley et al. · Science · 2024 · 207 citations · Full text
Medicine, Immunology, Oncology +17
Robert Zorc, Christopher Redmond, McKella Sylvester et al. · Annals of the Rheumatic Diseases · 2025 · 10 citations · Full text
1–2 of 2